EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

Camille N Kotton iD, Julian Torre-Cisneros iD, Ibrahim Yakoub-Agha iD, CMV International Symposium Faculty

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14183 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Camille N Kotton und 3 weiteren Autor:innen. Beteiligte Einrichtung: Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Bost…. Hauptthemen laut MEDLINE: Organ Transplantation, Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotest AG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2023 International CMV Symposium took place in Barcelona in May 2023. During the 2‐day meeting, delegates and faculty discussed the ongoing challenge of managing the risk of cytomegalovirus infection (the Troll of Transplantation) after solid organ or hematopoietic cell transplantation. Opportunities to improve outcomes of transplant recipients by applying advances in antiviral prophylaxis or pre‐emptive therapy, immunotherapy, and monitoring of cell‐mediated immunity to routine clinical practice were debated and relevant educational clinical cases presented. This review summarizes the presentations, cases, and discussions from the meeting and describes how further advances are needed before the Troll of Transplantation is slain. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organ TransplantationCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationHumansCytomegalovirusAntiviral Agents

Stichwörter der Autor:innen

CMV immunoglobulincell-mediated immunityhematopoietic cell transplantresistancesolid organ transplantvaccines

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Maimónides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofía University Hospital/University of Cordoba (UCO), Cordoba, Spain.
  • CIBERINFEC, ISCIII - CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • CHU de Lille, Univ Lille, Lille, France.

ORCID-Profile: Camille N Kotton, Julian Torre-Cisneros, Ibrahim Yakoub-Agha

Förderung

  • Biotest AG

Zitieren

APA

Kotton, C. N., Torre-Cisneros, J., Yakoub-Agha, I., & CMV International Symposium Faculty (2024). Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023. Transplant Infectious Disease. https://doi.org/10.1111/tid.14183

Vancouver

Kotton CN, Torre-Cisneros J, Yakoub-Agha I, CMV International Symposium Faculty. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023. Transplant Infectious Disease. 2024. doi:10.1111/tid.14183

BibTeX
@article{Kotton2024,
  author = {Kotton, Camille N and Torre-Cisneros, Julian and Yakoub-Agha, Ibrahim and CMV International Symposium Faculty, CMV International Symposium Faculty},
  title = {Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14183}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche